Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Evotec AG    EVT   DE0005664809

EVOTEC AG (EVT)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about EVOTEC AG
01:40p CORRECTION OF A RELEASE FROM 11.12.2 : 40 CET/CEST - Evotec AG: Release accordin..
12/11 EVOTEC : Academic Bridge LAB282 with Oxford University Celebrating One Year of I..
12/11 EVOTEC AG : Release according to Article 26, Section 1 of the WpHG [the German S..
12/11 EVOTEC : S academic bridge lab282 with oxford university celebrating one year of..
12/04 EVOTEC : receives clinical milestone as part of its discovery alliance with Boeh..
12/01 EVOTEC : Receives clinical milestone as part of its discovery alliance with boeh..
12/01 EVOTEC : Receives clinical milestone as part of its discovery alliance with boeh..
11/30 EVOTEC AG : Release according to Article 26a of the WpHG [the German Securities ..
11/14 EVOTEC AG : announces first nine-month 2017 results and corporate update
11/09 EVOTEC : to Attend Upcoming Investor Conferences
11/09 EVOTEC : To attend upcoming investor conferences
11/09 EVOTEC : joins forces with academic leaders to accelerate drug discovery in kidn..
11/08 EVOTEC AG : Announces First Nine-Month 2017 Results and Corporate Update
11/08 EVOTEC : Announces first nine-month 2017 results and corporate update
11/06 EVOTEC AG : to report first nine-month 2017 results on 08 November 2017
More most relevant news
All news about EVOTEC AG
01:40p CORRECTION OF A RELEASE FROM 11.12.2 : 40 CET/CEST - Evotec AG: Release accordin..
12/11 EVOTEC : Academic Bridge LAB282 with Oxford University Celebrating One Year of I..
12/11 EVOTEC AG : Release according to Article 26, Section 1 of the WpHG [the German S..
12/11 EVOTEC : S academic bridge lab282 with oxford university celebrating one year of..
12/04 EVOTEC : receives clinical milestone as part of its discovery alliance with Boeh..
12/01 EVOTEC : Receives clinical milestone as part of its discovery alliance with boeh..
12/01 EVOTEC : Receives clinical milestone as part of its discovery alliance with boeh..
11/30 EVOTEC AG : Release according to Article 26a of the WpHG [the German Securities ..
11/29 EVOTEC : Fibrocor Therapeutics Appoints Its First President & CEO
11/14 EVOTEC AG : announces first nine-month 2017 results and corporate update
More news
Sector news : Biotechnology & Medical Research - NEC
12:46p Sanofi investors hungry for drug progress and deal news
10:43a M&A dominates Europe share trading as oil leads gains
12/09 Tax-loss selling to pressure 2017's losers in December
11/30 GENMAB : and J&J 'love' partnership as some ponder takeover
11/27 MERCK AND : As Brexit looms, UK pitches new industry plan, wins support from Mer..
11/27 MERCK AND : As Brexit looms, UK pitches new industry plan, wins support from Mer..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
11/17 Evotec (EVTCY) Presents At Jefferies 2017 London Healthcare Conference - Slid..
11/11 Evotec's (EVOTF) CEO Werner Lanthaler on Q3 2017 Results - Earnings Call Tran..
11/08 MY JOURNEY TO FINANCIAL INDEPENDENCE : 85-Stock October Portfolio Update - Buyin..
11/08 Evotec AG ADR 2017 Q3 - Results - Earnings Call Slides
11/08 Evotec AG reports Q3 results
10/20 Evotec short pitch at Robin Hood conference; shares fall 4%
Financials (€)
Sales 2017 246 M
EBIT 2017 46,2 M
Net income 2017 28,9 M
Debt 2017 103 M
Yield 2017 -
P/E ratio 2017 71,75
P/E ratio 2018 49,25
EV / Sales 2017 9,15x
EV / Sales 2018 6,82x
Capitalization 2 143 M
Chart EVOTEC AG
Duration : Period :
Evotec AG Technical Analysis Chart | EVT | DE0005664809 | 4-Traders
Technical analysis trends EVOTEC AG
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 17,5 €
Spread / Average Target 21%
EPS Revisions
Managers
NameTitle
Werner Lanthaler Chief Executive Officer
Wolfgang Plischke Chairman-Supervisory Board
Mario Polywka Chief Operating Officer
Enno Spillner Chief Financial Officer
Cord E. Dohrmann Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
EVOTEC AG74.01%2 524
CELLTRION, INC.--.--%23 085
IQVIA HOLDINGS INC32.70%21 148
INCYTE CORPORATION-5.43%20 523
LONZA GROUP57.44%19 299
ALNYLAM PHARMACEUTICALS, INC.243.83%12 606